Strategic Blueprint’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Strategic Blueprint’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,564	Closed	-$208K	–	536
2021 Q4	$208K	Sell	2,564 -83	-3%	-$6.56K	0.03%	465
2021 Q3	$205K	Sell	2,647 -309	-10%	-$24.9K	0.03%	384
2021 Q2	$238K	Sell	2,956 -61	-2%	-$4.84K	0.04%	346
2021 Q1	$238K	Sell	3,017 -784	-21%	-$61.2K	0.05%	270
2020 Q4	$271K	Buy	+3,801	New	+$254K	0.07%	207
2019 Q4	–	Sell	-23	Closed	-$1K	–	331
2019 Q3	$1K	Buy	+23	New	+$1.32K	﹤0.01%	426

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Strategic Blueprint's PJP Position: Q1 2022 in Review

Strategic Blueprint sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2022, closing a stake of 2,564 shares — an estimated $208K sold.

Strategic Blueprint first reported a position in PJP in Q3 2019 and held it in 6 quarters. The position peaked at $271K in Q4 2020. 88 funds tracked by Wall St. Rank hold PJP as of Q1 2022.

Strategic Blueprint reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2022 after selling out during the quarter.
Strategic Blueprint sold 2,564 Invesco Pharmaceuticals ETF shares in Q1 2022, an estimated $208K.
Strategic Blueprint first reported a position in Invesco Pharmaceuticals ETF in Q3 2019 and held it in 6 quarters.
Strategic Blueprint's Invesco Pharmaceuticals ETF position peaked at $271K in Q4 2020.
88 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2022.

Based on Strategic Blueprint's 13F filing for Q1 2022, filed 12 Aug 2022.